How did BKYI's Q1 2025 EPS forecast compare to past trends?

BIO-key International Inc.'s (BKYI) Q1 2025 EPS forecast is not currently available. However, based on the available data, the company's EPS has fluctuated significantly over the past few years.

1. **Recent Performance**: In Q4 2024, BIO-key reported a GAAP EPS of -$0.53, which is a decline from the previous quarter's EPS of -$1.00. This suggests a short-term improvement in earnings.
2. **Long-term Trends**: The company's EPS has shown a general upward trend. For instance, the EPS in 2023 was -$15.21, and in 2022, it was -$27.26. In contrast, the EPS in 2021 was -$11.69, and in 2020, it was -$37.41. This indicates a potential recovery or stabilization of the EPS in recent years.
3. **Comparison with Estimates**: In Q4 2024, BIO-key missed analysts' estimates by $0.46 per share, with an EPS of $1.00 compared to the estimated -$0.54. This discrepancy suggests that the company's actual performance may differ from market expectations.
4. **Market Perception**: Short interest in BIO-key International has increased significantly, with a 123.1% growth in June 2024. This could indicate heightened market skepticism or uncertainty regarding the company's future performance.

In conclusion, while BIO-key's Q1 2025 EPS forecast is not currently available, the company's past trends show significant fluctuations with a potential for improvement. However, the recent miss of earnings estimates and increased short interest suggest that investors may have concerns about the company's future performance.